These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 806094)

  • 1. Tumor microvasculature following fractionated x irradiation.
    Hilmas DE; Gillette EL
    Radiology; 1975 Jul; 116(1):165-9. PubMed ID: 806094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvasculature of C3H/Bi mouse mammary tumors after x-irradiation.
    Hilmas DE; Gillette EL
    Radiat Res; 1975 Jan; 61(1):128-43. PubMed ID: 1110971
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphometric analyses of the microvasculature of tumors during growth and after x-irradiation.
    Hilmas DE; Gillette EL
    Cancer; 1974 Jan; 33(1):103-10. PubMed ID: 4810083
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
    Horsman MR; Nielsen T; Østergaard L; Overgaard J
    Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of tumor cell behavior following single daily or multiple daily (accelerated) irradiation in mammary cancer in C3H mice].
    Pfersdorff J; Sack H
    Strahlenther Onkol; 1986 Nov; 162(11):723-8. PubMed ID: 3787456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic delay after fractionated irradiation of autotransplants of a spontaneous mouse tumor.
    Seydel HG
    Am J Roentgenol Radium Ther Nucl Med; 1967 Aug; 100(4):938-43. PubMed ID: 4951461
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying reduced growth rate in C3HBA mammary adenocarcinomas recurring after single doses of x-rays or fast neutrons.
    Nelson JS; Carpenter RE; Durboraw D
    Cancer Res; 1976 Feb; 36(2 Pt 1):524-31. PubMed ID: 1260751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo.
    Molin J; Søgaard PE; Overgaard J
    Cancer Treat Rep; 1981; 65(7-8):583-9. PubMed ID: 6166372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial comparative response of experimental tumors to peak pions and x rays.
    Kligerman MM; DiCello JF; Davis HT; Thomas RA; Sternhagen CJ; Gomez L; Peterson DF
    Radiology; 1975 Jul; 116(1):181-2. PubMed ID: 806096
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
    Rockwell S
    J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence of response of a C3H mammary carcinoma to fractionated irradiation on fractionation number and intertreatment interval.
    Suit HD; Howes AE; Hunter N
    Radiat Res; 1977 Dec; 72(3):440-54. PubMed ID: 594321
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose fractionation schedules--biologic aspects and applications to high LET radiotherapy.
    Fowler JF
    J Can Assoc Radiol; 1975 Mar; 26(1):40-3. PubMed ID: 806599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor control by irradiation: A C3H-He mouse mammary carcinoma in mammary-tumor-agent-positive and mammary-tumor-agent-free mice.
    Suit H; Kastelan A
    J Natl Cancer Inst; 1968 May; 40(5):945-50. PubMed ID: 5648138
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma.
    Grau C; Overgaard J
    Radiat Res; 1990 Jun; 122(3):309-15. PubMed ID: 2356285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of an active specific immunotherapy modified with irradiation. 2. Inhibiton of transplanted MM46-tumor growth in C3H/He mice pretreated with immunotherapy].
    Imanaka K; Ogawa Y; Takashima H; Okuno T; Inomata Y; Ichiyanagi A; Ashida C; Gose K; Oshitani T; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Jun; 17(4):1043-47. PubMed ID: 7130794
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.
    Suit HD; Sedlacek R; Silver G; Hsieh CC; Epp ER; Ngo FQ; Roberts WK; Verhey L
    Radiat Res; 1988 Dec; 116(3):482-502. PubMed ID: 3205910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
    Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
    Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in tumor microvascular response to radiation.
    Dewhirst MW; Oliver R; Tso CY; Gustafson C; Secomb T; Gross JF
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):559-68. PubMed ID: 2318688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.